![Lisbon Addictions 2024](/files/styles/card/public/2023-10/logo-2024.png?itok=OZCkBZh0)
![Lisbon Addictions 2024](/files/styles/card/public/2023-10/logo-2024.png?itok=OZCkBZh0)
Laporan Obat Eropa 2023: Tren dan Perkembangan menyajikan analisis terbaru EMCDDA tentang situasi obat di Eropa. Berfokus pada penggunaan obat-obatan terlarang, bahaya terkait dan pasokan obat-obatan, laporan ini berisi serangkaian data...
Despite extensive evidence regarding the negative effects of stigma experienced by people living with HIV (PLHIV) and people who inject drugs within health care settings, comparatively little evidence exists regarding the effectiveness of...
Alkohol dan perawatan obat lainnya umumnya hanya disediakan untuk individu, seringkali jauh dari keluarga mereka. Pengobatan bertujuan untuk meningkatkan kesejahteraan dan mengurangi bahaya penggunaan narkoba dan keluarga serta masyarakat...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Gangguan penggunaan zat (SUD) sangat lazim dan berdampak pada kesehatan, kesejahteraan, dan fungsi sosial individu. Perubahan jangka panjang dalam jaringan otak yang terlibat dalam penghargaan, fungsi eksekutif, reaktivitas stres...
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...
In the magazine CIJ Informa, the participation of CIJ, host chapter institution of ISSUP Mexico, in the 71st Regular Session of CICAD is reviewed.
The Anti-Stigma Network has been launched!
The Anti-Stigma Network has been created by a group of organisations coming together with a shared mission.
Collectively they aim to improve understanding of the stigma and...
Latar
Ketergantungan opioid dikaitkan dengan beban kesehatan dan sosial yang substansial, dan pengobatan agonis opioid (OAT) sangat efektif dalam meningkatkan berbagai hasil bagi orang yang menerima perawatan ini. Metadon...
Krisis penggunaan opioid membebani sumber daya di Amerika Serikat dan di seluruh dunia. Ada 3 obat yang disetujui oleh Food and Drug Administration AS untuk pengobatan gangguan penggunaan opioid: metadon, buprenorfin...
Pertanyaan: Perawatan apa untuk gangguan penggunaan kokain yang terkait dengan pengurangan obyektif dalam penggunaan kokain di kalangan orang dewasa?
Dalam meta-analisis dari 157 uji klinis yang terdiri dari 402...
Cocaine is an addictive stimulant drug that originates from the leaves of the coca plant, which is indigenous to South America. The drug's effects include heightened alertness, attention, and energy, as well as feelings of euphoria and...
The markets for hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSC) are rapidly evolving areas with relatively limited information currently available.
The European situation presented in Section 1 can...
Objective: To better understand current developments in the treatment of stimulant use.
Background: Stimulant drugs are second only to cannabis as the most widely used class of illicit drug globally, accounting for 68 million past...
Substance misuse among young people is one of the most public concerns in global health. This study set out to explore treatment barriers among young people in Zimbabwe.
Data was collected through interviews with 30 participants
The...
It has been widely reported that youth alcohol consumption has decreased over recent years. What is the evidence to support this view? What are the implications for alcohol related health harm, promotion of safe drinking and health policy?
...This report presents the most recent and in-depth data on overdose and drug-induced deaths in Australia, covering the period 2002 to 2021. It is the most recent output in a series of annual publications on trends in drug overdose deaths...
Share the Knowledge: ISSUP members can post in the Knowledge Share – Sign in or become a member